发明名称 BETA 3 AGONIST AND USE THEREOF
摘要 PROBLEM TO BE SOLVED: To provide a sulfamide compound acting as a selectiveβ3 agonist and a pharmaceutical composition comprising the sulfamide compound. SOLUTION: This sulfamide compound is represented by the formula (I) (wherein, e.g. R<0> , R<1> , R<4> and R<5> are each hydrogen; R<2> and R<3> are each methyl group; Ar is 3-chlorophenyl group; X is a covalent bond; and R<6> and R<7> are each methylene group and together form a 6-membered ring). [N-[4-[2-[[(2 R)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]-2-methylpropyl]phenyl]-1- piperidinesulfonamide]. The pharmaceutical composition comprising the compound can be used in treatment of diseases dependent on the signaling pathway associated withβ-adrenergic receptors, e.g. obesity, diabetes, hypertension, gastrointestinal hypo- or hyper-motility and cardiovascular diseases.
申请公布号 JP2002326983(A) 申请公布日期 2002.11.15
申请号 JP20020051109 申请日期 2002.02.27
申请人 PFIZER PROD INC 发明人 DOW ROBERT LEE;PAIGHT ERNEST SIDNEY JR
分类号 C07D295/22;A61K31/18;A61K31/438;A61K31/4406;A61K31/443;A61K31/4439;A61K31/4453;A61K31/4545;A61K31/4725;A61K31/496;A61K31/5377;A61K31/551;A61P1/00;A61P1/04;A61P1/14;A61P3/00;A61P3/04;A61P3/06;A61P3/10;A61P9/00;A61P9/12;A61P11/00;A61P11/06;A61P13/00;A61P13/08;A61P25/24;A61P43/00;C07C307/10;C07D209/52;C07D213/38;C07D213/42;C07D295/26;C07D401/12;C07D405/12;C07D413/12;(IPC1-7):C07C307/10;A61K31/440;A61K31/445;A61K31/454;A61K31/472;A61K31/537 主分类号 C07D295/22
代理机构 代理人
主权项
地址